Spherix Inc  

(Public, NASDAQ:SPEX)   Watch this stock  
Find more results for SPEX
+0.55 (49.11%)
Real-time:   11:58AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.28 - 1.97
52 week 0.83 - 2.59
Open 1.28
Vol / Avg. 9.17M/109,858.00
Mkt cap 9.27M
P/E 0.21
Div/yield     -
EPS 8.11
Shares 4.94M
Beta 1.04
Inst. own 4%

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin -281.04% -738.43%
Operating margin -296.33% -975.03%
EBITD margin - -421.89%
Return on average assets -34.52% -51.87%
Return on average equity -75.84% 355.47%
Employees 3 -
CDP Score - -


1 Rockefeller Plz Fl 11
NEW YORK, NY 10020-2073
United States - Map
+1-347-3217646 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Spherix Incorporated is an intellectual property company that owns patented and unpatented intellectual property. The Company is a patent commercialization company focused on generating revenues from the monetization of intellectual property. The Company acquires intellectual property from patent holders in order to maximize the value of the patent holdings by conducting and managing a licensing campaign. Its activities generally include the acquisition and development of patents through internal or external research and development. In addition, it seeks to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications. Its patent portfolio includes both the United States and foreign patents and pending patent applications in the wireless communications and telecommunication sectors, including data, optical and voice technology, antenna technology, wireless fidelity (Wi-Fi), base station functionality, and cellular.

Officers and directors

Robert J. Vander Zanden Ph.D. Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Anthony Hayes Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Director
Age: 48
Bio & Compensation  - Reuters
Eric Weisblum Director
Bio & Compensation  - Reuters
Douglas T. Brown Independent Director
Age: 60
Bio & Compensation  - Reuters
Tim S. Ledwick Independent Director
Age: 57
Bio & Compensation  - Reuters